NEA Management Company, LLC Q3 2020 Filing
Filed November 6, 2020
Portfolio Value
$2.4T
Holdings
54
Report Date
Q3 2020
Filing Type
13F-HR
All Holdings (54 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | SPTSPROUT SOCIAL INC | 5,596,080 | $215.4B | 9.12% | |
| 2 | ALLKGUSDALLAKOS INC | 2,268,188 | $184.7B | 7.82% | |
| 3 | ADAPYADAPTIMMUNE THERAPEUTICS PLC | 17,082,611 | $136.3B | 5.77% | |
| 4 | CRSPCRISPR THERAPEUTICS AG | 1,590,002 | $133.0B | 5.63% | |
| 5 | OYSTOYSTER PT PHARMA INC | 5,925,287 | $125.1B | 5.30% | |
| 6 | —MERSANA THERAPEUTICS INC | 5,959,520 | $111.0B | 4.70% | |
| 7 | RYTMRHYTHM PHARMACEUTICALS INC | 4,912,306 | $106.5B | 4.51% | |
| 8 | BDTXBLACK DIAMOND THERAPEUTICS INC | 3,449,845 | $104.3B | 4.42% | |
| 9 | —AKOUOS INC | 4,298,488 | $98.3B | 4.16% | |
| 10 | NKTXNKARTA INC | 2,904,974 | $87.3B | 3.70% | |
| 11 | —IMARA INC | 4,017,170 | $81.7B | 3.46% | |
| 12 | TREURTRILLIUM THERAPEUTICS INC | 5,736,363 | $81.5B | 3.45% | |
| 13 | MIRMMIRUM PHARMACEUTICALS INC | 4,187,801 | $80.7B | 3.42% | |
| 14 | AUPHAURINIA PHARMACEUTICALS INC | 5,172,683 | $76.2B | 3.23% | |
| 15 | ANNXANNEXON INC | 2,497,661 | $75.5B | 3.20% | |
| 16 | ARDXARDELYX INC | 13,633,582 | $71.6B | 3.03% | |
| 17 | INZYINOZYME PHARMA INC | 2,444,379 | $64.3B | 2.72% | |
| 18 | —CASPER SLEEP INC | 6,226,130 | $44.8B | 1.90% | |
| 19 | GRTXGALERA THERAPEUTICS INC | 4,362,986 | $39.4B | 1.67% | |
| 20 | VRNAVERONA PHARMA PLC | 5,108,563 | $31.9B | 1.35% | |
| 21 | —METACRINE INC | 3,062,977 | $31.3B | 1.32% | |
| 22 | GLYCEURGLYCOMIMETICS INC | 9,089,041 | $27.9B | 1.18% | |
| 23 | MEIPUSDMEI PHARMA INC | 8,533,072 | $26.6B | 1.13% | |
| 24 | BEBLOOM ENERGY CORP | 1,333,333 | $24.0B | 1.01% | |
| 25 | TRVITREVI THERAPEUTICS INC | 5,940,796 | $23.9B | 1.01% | |
| 26 | GNCAQGENOCEA BIOSCIENCES INC | 10,376,936 | $23.8B | 1.01% | |
| 27 | 0HJQAVEO PHARMACEUTICALS INC | 3,952,958 | $23.5B | 0.99% | |
| 28 | GONGERON CORP | 13,461,538 | $23.4B | 0.99% | |
| 29 | —PHASEBIO PHARMACEUTICALS INC | 6,643,704 | $23.3B | 0.99% | |
| 30 | —AFFIMED NV | 6,126,488 | $20.8B | 0.88% | |
| 31 | CSBRCHAMPIONS ONCOLOGY INC | 1,713,720 | $15.9B | 0.67% | |
| 32 | CTIC1USDCTI BIOPHARMA CORP | 7,140,450 | $15.4B | 0.65% | |
| 33 | IVAINVENTIVA SA | 1,041,666 | $12.3B | 0.52% | |
| 34 | LQDALIQUIDIA TECHNOLOGIES INC | 2,486,062 | $12.2B | 0.52% | |
| 35 | —TREVENA INC | 3,811,691 | $11.4B | 0.48% | |
| 36 | —OBSEVA SA | 4,586,563 | $11.4B | 0.48% | |
| 37 | NETCLOUDFLARE INC | 2,763,583 | $11.3B | 0.48% | |
| 38 | XENEXENON PHARMACEUTICALS INC | 992,107 | $11.0B | 0.47% | |
| 39 | DZSIQDZS INC | 956,255 | $9.0B | 0.38% | |
| 40 | —STRONGBRIDGE BIOPHARMA PLC | 4,141,308 | $8.7B | 0.37% | |
| 41 | —SYNLOGIC INC | 4,229,410 | $8.5B | 0.36% | |
| 42 | TPIVDEURMARKER THERAPEUTICS INC | 5,000,000 | $7.5B | 0.32% | |
| 43 | 4NX1LUMOS PHARMA INC | 526,663 | $7.3B | 0.31% | |
| 44 | SENS1GBPSENSEONICS HOLDINGS INC | 14,153,201 | $5.5B | 0.23% | |
| 45 | ERYP1EURERYTECH PHARMA SA | 625,000 | $3.8B | 0.16% | |
| 46 | LXRXLEXICON PHARMACEUTICALS INC | 2,382,286 | $3.4B | 0.15% | |
| 47 | —MILLENDO THERAPEUTICS INC | 1,766,779 | $2.9B | 0.12% | |
| 48 | TCONTRACON PHARMACEUTICALS INC | 346,718 | $1.8B | 0.08% | |
| 49 | DKNG1USDDRAFTKINGS INC | 23,902 | $1.4B | 0.06% | |
| 50 | —REGULUS THERAPEUTICS INC | 2,052,455 | $1.1B | 0.04% | |
| 51 | —AKARI THERAPEUTICS PLC | 452,167 | $787.0M | 0.03% | |
| 52 | PLTRPALANTIR TECHNOLOGIES INC | 74,974 | $712.0M | 0.03% | |
| 53 | ALTREURALTAIR ENGR INC | 11,977 | $503.0M | 0.02% | |
| 54 | —SUNESIS PHARMACEUTICALS INC | 129,827 | $162.0M | 0.01% |